An AI-powered blood test that analyzes DNA fragments could detect silent liver disease long before symptoms begin. Scientists at the Johns Hopkins Kimmel Cancer Center have developed an artificial intelligence (AI) powered liquid biopsy that may identify liver fibrosis and…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.